A Study of Isatuximab-based Therapy in Participants With Lymphoma

NCT03769181 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
58
Enrollment
INDUSTRY
Sponsor class

Stopped Study was stopped after interim analysis for all 4 cohorts with results either not fulfilling the pre-planned interim analysis criteria or fulfilling the criteria but as per sponsor decision. It was not due to any safety concern

Conditions

Interventions

Sponsor

Sanofi